Novel Therapeutic Cancer Vaccine Goes to Human Clinical Trials

Says the article on Science Daily’s website, “A cross-disciplinary team of scientists, engineers, and clinicians announced today that they have begun a Phase I clinical trial of an implantable vaccine to treat melanoma, the most lethal form of skin cancer.”

MY TAKE-Sounds impressive, doesn’t it? Based on everything I’ve studied, published and spoken about regarding cancer during the past few decades, if this vaccine has no antifungal properties, it simply won’t work. 

Of course, that doesn’t mean that it won’t be marketed and sold for many decades like the PSA test still is. Even though the PSA test is a mere 3.8% accurate in detecting prostate cancer, the FDA approved it long ago and many men will continue having it run until a whistleblower comes forth.

My friend, Dr. A. V. Costantini, showed that the PSA test was a fungal test all along. Yet in my opinion, the PSA test values for “prostate fungus” were set way too low to call it “prostate cancer,” otherwise it might have worked as a prostate “cancer” test, given the similarities of the two! 

It seems that much money and powerful medical institutions and doctors are behind this new cancer vaccine, so get ready America! Just remember, you read it first right here on Know The Cause!



Share on facebook
Share on Facebook
Share on reddit
Share on Reddit
Share on email
Share via Email
Share on twitter
Share on Twitter

Leave a Reply